|
1
|
Tyack ZF, Pegg S and Ziviani J: Postburn
dyspigmentation: Its assessment, management, and relationship to
scarring-a review of the literature. J Burn Care Rehabil.
18:435–440. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Das S and Baker AB: Biomaterials and
nanotherapeutics for enhancing skin wound healing. Front Bioeng
Biotechnol. 4:822016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gauglitz GG, Korting HC, Pavicic T,
Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids:
Pathomechanisms and current and emerging treatment strategies. Mol
Med. 17:113–125. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sidgwick GP, Iqbal SA and Bayat A: Altered
expression of hyaluronan synthase and hyaluronidase mRNA may affect
hyaluronic acid distribution in keloid disease compared with normal
skin. Exp Dermatol. 22:377–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meyer LJ, Russell SB, Russell JD, Trupin
JS, Egbert BM, Shuster S and Stern R: Reduced hyaluronan in keloid
tissue and cultured keloid fibroblasts. J Invest Dermatol.
114:953–959. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Syed F, Ahmadi E, Iqbal SA, Singh S,
McGrouther DA and Bayat A: Fibroblasts from the growing margin of
keloid scars produce higher levels of collagen I and III compared
with intralesional and extralesional sites: Clinical implications
for lesional site-directed therapy. Br J Dermatol. 164:83–96. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zuccaro J, Ziolkowski N and Fish J: A
systematic review of the effectiveness of laser therapy for
hypertrophic burn scars. Clin Plast Surg. 44:767–779. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kashiyama K, Mitsutake N, Matsuse M, Ogi
T, Saenko VA, Ujifuku K, Utani A, Hirano A and Yamashita S:
miR-196a downregulation increases the expression of type I and III
collagens in keloid fibroblasts. J Invest Dermatol. 132:1597–1604.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li P, He QY and Luo CQ: Overexpression of
miR-200b inhibits the cell proliferation and promotes apoptosis of
human hypertrophic scar fibroblasts in vitro. J Dermatol.
41:903–911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Li J, Tian L, Zhou C, Gao Y, Zhou
F, Shi S, Feng X, Sun N, Yao R, et al: MiRNA expression profile
reveals a prognostic signature for esophageal squamous cell
carcinoma. Cancer Lett. 350:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee HJ: Exceptional stories of microRNAs.
Exp Biol Med (Maywood). 238:339–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McCarthy JJ: The MyomiR network in
skeletal muscle plasticity. Exerc Sport Sci Rev. 39:150–154. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heinrich EM and Dimmeler S: MicroRNAs and
stem cells: Control of pluripotency, reprogramming, and lineage
commitment. Circ Res. 110:1014–1022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou ZJ, Fan L, Wang L, Xu J, Zhang R, Tian
T, Li JY and Xu W: miR-26a and miR-214 down-regulate expression of
the PTEN gene in chronic lymphocytic leukemia, but not PTEN
mutation or promoter methylation. Oncotarget. 6:1276–1285. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao F, Xu G, Zhou Y, Wang L, Xie J, Ren
S, Liu S and Zhu Y: MicroRNA-26b inhibits hepatitis B virus
transcription and replication by targeting the host factor CHORDC1
protein. J Biol Chem. 289:35029–35041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao S, Ye X, Xiao L, Lian X, Feng Y, Li F
and Li L: MiR-26a inhibits prostate cancer progression by
repression of Wnt5a. Tumour Biol. 35:9725–9733. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen W, Song M, Liu J, Qiu G, Li T, Hu Y
and Liu H: MiR-26a promotes ovarian cancer proliferation and
tumorigenesis. PLoS One. 9:e868712014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian H, Yang C and Yang Y: MicroRNA-26a
inhibits the growth and invasiveness of malignant melanoma and
directly targets on MITF gene. Cell Death Discov. 3:170282017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolfram D, Tzankov A, Pülzl P and
Piza-Katzer H: Hypertrophic scars and keloids-a review of their
pathophysiology, risk factors, and therapeutic management. Dermatol
Surg. 35:171–181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han SB, Shin YJ, Hyon JY and Wee WR:
Cytotoxicity of voriconazole on cultured human corneal endothelial
cells. Antimicrob Agents Chemother. 55:4519–4523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao J and Liu QG: The role of miR-26 in
tumors and normal tissues (Review). Oncol Lett. 2:1019–1023. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang B, Liu XX, He JR, Zhou CX, Guo M, He
M, Li MF, Chen GQ and Zhao Q: Pathologically decreased miR-26a
antagonizes apoptosis and facilitates carcinogenesis by targeting
MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Babalola O, Mamalis A, Lev-Tov H and
Jagdeo J: The role of microRNAs in skin fibrosis. Arch Dermatol
Res. 305:763–776. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang WH, Deng AJ and He SG: A key role of
microRNA-26a in the scar formation after glaucoma filtration
surgery. Artif Cells Nanomed Biotechnol. 7:1–7. 2017. View Article : Google Scholar
|
|
27
|
Hao R, Chen L, Wu JW and Wang ZX:
Structure of drosophila Mad MH2 domain. Acta Crystallogr Sect F
Struct Biol Cryst Commun. 64:986–990. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moustakas A, Souchelnytskyi S and Heldin
CH: Smad regulation in TGF-beta signal transduction. J Cell Sci.
114:4359–4369. 2011.
|
|
29
|
Froese AR, Shimbori C, Bellaye PS, Inman
M, Obex S, Fatima S, Jenkins G, Gauldie J, Ask K and Kolb M:
Stretch-induced activation of transforming growth factor-β1 in
pulmonary fibrosis. Am J Respir Crit Care Med. 194:84–96. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao S, Xiao L, Rao JN, Zou T, Liu L, Zhang
D, Turner DJ, Gorospe M and Wang JY: Inhibition of Smurf2
translation by miR-322/503 modulates TGF-β/Smad2 signaling and
intestinal epithelial homeostasis. Mol Biol Cell. 25:1234–1243.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin K, Yin W, Wang Y, Zhou L, Liu Y, Yang
G, Wang J and Lu J: MiR-206 suppresses epithelial mesenchymal
transition by targeting TGF-β signaling in estrogen receptor
positive breast cancer cells. Oncotarget. 7:24537–24548.
2016.PubMed/NCBI
|
|
32
|
Zuo J, Chen Z, Zhong X, Lan W, Kuang Y and
Huang D: FBP1 is highly expressed in human hypertrophic scars and
increases fibroblast proliferation, apoptosis, and collagen
expression. Connect Tissue Res. 31:1–9. 2017.
|
|
33
|
Li J, Chen L, Cao C, Yan H, Zhou B, Gao Y,
Li Q and Li J: The long non-coding RNA LncRNA8975-1 is upregulated
in hypertrophic scar fibroblasts and controls collagen expression.
Cell Physiol Biochem. 40:326–334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou R, Zhang Q, Zhang Y, Fu S and Wang C:
Aberrant miR-21 and miR-200b expression and its pro-fibrotic
potential in hypertrophic scars. Exp Cell Res. 339:360–366. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan C, Dong Y, Xie Y, Su Y, Zhang X,
Leavesley D and Upton Z: Shikonin reduces TGF-β1-induced collagen
production and contraction in hypertrophic scar-derived human skin
fibroblasts. Int J Mol Med. 36:985–991. 2015. View Article : Google Scholar : PubMed/NCBI
|
